ATE507720T1 - Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands - Google Patents

Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands

Info

Publication number
ATE507720T1
ATE507720T1 AT06825270T AT06825270T ATE507720T1 AT E507720 T1 ATE507720 T1 AT E507720T1 AT 06825270 T AT06825270 T AT 06825270T AT 06825270 T AT06825270 T AT 06825270T AT E507720 T1 ATE507720 T1 AT E507720T1
Authority
AT
Austria
Prior art keywords
prognosis
diagnosis
lysophosphatidylcholine
inflammatory condition
detection
Prior art date
Application number
AT06825270T
Other languages
English (en)
Inventor
Song Shi
Thomas Gentle
Richard Moore
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Application granted granted Critical
Publication of ATE507720T1 publication Critical patent/ATE507720T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/26Infectious diseases, e.g. generalised sepsis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT06825270T 2005-09-28 2006-09-27 Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands ATE507720T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72183305P 2005-09-28 2005-09-28
US76291106P 2006-01-27 2006-01-27
US84140706P 2006-08-30 2006-08-30
PCT/US2006/038177 WO2007038758A2 (en) 2005-09-28 2006-09-27 Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition

Publications (1)

Publication Number Publication Date
ATE507720T1 true ATE507720T1 (de) 2011-05-15

Family

ID=37900497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06825270T ATE507720T1 (de) 2005-09-28 2006-09-27 Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands

Country Status (10)

Country Link
US (2) US8183050B2 (de)
EP (1) EP1940231B1 (de)
JP (1) JP5183480B2 (de)
KR (1) KR101281298B1 (de)
AT (1) ATE507720T1 (de)
AU (1) AU2006294481B2 (de)
BR (1) BRPI0616720A2 (de)
CA (1) CA2623523C (de)
DE (1) DE602006021768D1 (de)
WO (1) WO2007038758A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1869463A4 (de) 2005-04-15 2010-05-05 Becton Dickinson Co Sepsisdiagnose
ATE507720T1 (de) 2005-09-28 2011-05-15 Becton Dickinson Co Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands
US20090104605A1 (en) * 2006-12-14 2009-04-23 Gary Siuzdak Diagnosis of sepsis
EP2183694B1 (de) * 2007-07-13 2019-04-17 Koninklijke Philips N.V. Entscheidungsunterstützungssystem für akute dynamische krankheiten
WO2009096903A1 (en) * 2008-01-28 2009-08-06 National University Of Singapore Lipid tumour profile
WO2009126380A2 (en) * 2008-03-05 2009-10-15 Singulex, Inc. Methods and compositions for highly sensitive detection of molecules
US8669113B2 (en) 2008-04-03 2014-03-11 Becton, Dickinson And Company Advanced detection of sepsis
EP2391886A4 (de) * 2009-04-10 2013-04-17 Canon Kk Verfahren zur formung einer massenabbildung
AU2010259022B2 (en) 2009-06-08 2016-05-12 Singulex, Inc. Highly sensitive biomarker panels
US8600556B2 (en) * 2009-06-22 2013-12-03 Johnson Controls Technology Company Smart building manager
US8417541B1 (en) * 2009-08-27 2013-04-09 Cerner Innovation, Inc. Multi-stage model for predicting probabilities of mortality in adult critically ill patients
EP2339352A1 (de) 2009-12-28 2011-06-29 BIOCRATES Life Sciences AG Verwendung endogener Metaboliten zur frühen Sepsiserkennung
ITRM20100121A1 (it) * 2010-03-18 2011-09-19 Univ Pisa Marcatori molecolari per infezioni delle vie urinarie.
US20110301053A1 (en) 2010-05-06 2011-12-08 Singulex, Inc. Methods for Diagnosing, Staging, Predicting Risk for Developing and Identifying Treatment Responders for Rheumatoid Arthritis
US8904511B1 (en) 2010-08-23 2014-12-02 Amazon Technologies, Inc. Virtual firewalls for multi-tenant distributed services
US9336302B1 (en) 2012-07-20 2016-05-10 Zuci Realty Llc Insight and algorithmic clustering for automated synthesis
US20150285805A1 (en) 2012-11-05 2015-10-08 Ospedale San Raffaele S.R.L. Biomarkers of multiple myeloma development and progression
WO2014150329A1 (en) * 2013-03-14 2014-09-25 University Of Georgia Research Foundation, Inc. Lipid biomarkers of addiction and relapse risk
CN104458708A (zh) * 2013-09-12 2015-03-25 中国药科大学 一种筛选乙酰胆碱酯酶抑制剂高通量筛选方法
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
EP3433614A4 (de) * 2016-03-23 2019-12-11 Peach Intellihealth, Inc. Verwendung von klinischen parametern zur vorhersage von sirs
US11205103B2 (en) 2016-12-09 2021-12-21 The Research Foundation for the State University Semisupervised autoencoder for sentiment analysis
WO2019131578A1 (ja) 2017-12-26 2019-07-04 民男 山内 免疫動態に関する情報を提供する方法、システムおよびプログラム
KR102446591B1 (ko) * 2018-12-27 2022-09-22 고리츠다이가쿠호징 나라켕리츠 이카다이가쿠 간질성 방광염의 진단 방법
US20220146527A1 (en) * 2019-09-17 2022-05-12 Chang Gung University Method of creating characteristic profiles of mass spectra and identification model for analyzing and identifying features of microorganisms
KR102259533B1 (ko) * 2021-01-04 2021-06-02 주식회사 아리바이오 Lpc와 pct를 조합하는 패혈증 진단용 바이오마커 조성물 및 이를 이용한 진단방법
CN113189115B (zh) * 2021-05-17 2022-07-08 中国矿业大学 一种温度场测量及焊接缺陷在线监测装置及监测方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (de) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimäre Rezeptoren durch Verbindung und Expression von DNS
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
ES2108048T3 (es) 1990-08-29 1997-12-16 Genpharm Int Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
JPH05229993A (ja) 1991-12-13 1993-09-07 Fujirebio Inc トリフェニルメタン誘導体
US6190872B1 (en) 1994-05-06 2001-02-20 Gus J. Slotman Method for identifying and monitoring patients at risk for systemic inflammatory conditions and apparatus for use in this method
JP3436444B2 (ja) * 1995-07-21 2003-08-11 ヤマサ醤油株式会社 酸化hdlの測定法及びキット
US6248553B1 (en) * 1998-10-22 2001-06-19 Atairgin Technologies, Inc. Enzyme method for detecting lysophospholipids and phospholipids and for detecting and correlating conditions associated with altered levels of lysophospholipids
JP2002017938A (ja) 2000-07-07 2002-01-22 Toyo Kogyo Kk 脛当て
US7465555B2 (en) 2002-04-02 2008-12-16 Becton, Dickinson And Company Early detection of sepsis
US7015022B2 (en) * 2002-06-07 2006-03-21 University Of Medicine & Dentistry Of New Jersey Mammalian catalase-dependent oxidation processes and methods for stimulating oxidative activities
MXPA05005031A (es) 2002-11-12 2005-11-17 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
TW200418992A (en) * 2002-11-12 2004-10-01 Becton Dickinson Co Diagnosis of sepsis or sirs using biomarker profiles
CA2505843A1 (en) 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
WO2005034952A2 (en) * 2003-10-07 2005-04-21 The Feinstein Institute For Medical Research Isoxazole and isothiazole compounds useful in the treatment of inflammation
ATE507720T1 (de) 2005-09-28 2011-05-15 Becton Dickinson Co Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands
US8669113B2 (en) * 2008-04-03 2014-03-11 Becton, Dickinson And Company Advanced detection of sepsis

Also Published As

Publication number Publication date
EP1940231B1 (de) 2011-05-04
CA2623523C (en) 2019-02-12
BRPI0616720A2 (pt) 2011-06-28
CA2623523A1 (en) 2007-04-05
EP1940231A4 (de) 2008-12-31
KR101281298B1 (ko) 2013-07-08
EP1940231A2 (de) 2008-07-09
US8183050B2 (en) 2012-05-22
JP5183480B2 (ja) 2013-04-17
AU2006294481A1 (en) 2007-04-05
AU2006294481B2 (en) 2012-12-20
DE602006021768D1 (de) 2011-06-16
JP2009510450A (ja) 2009-03-12
US20070111316A1 (en) 2007-05-17
US20120301910A1 (en) 2012-11-29
WO2007038758A2 (en) 2007-04-05
WO2007038758A3 (en) 2007-09-13
KR20080068824A (ko) 2008-07-24

Similar Documents

Publication Publication Date Title
ATE507720T1 (de) Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands
CY1117784T1 (el) Μεθοδοι και συνθεσεις για διαγνωση και προγνωση νεφρικης βλαβης και νεφρικης ανεπαρκειας
DE602005020997D1 (de) Verfahrenshilfsmittel für elastomerzusammensetzungen
WO2010059242A3 (en) Neurodegenerative disease diagnostic compositions and methods of use
IL184905A0 (en) Method for diagnosing multiple sclerosis
DE602007011566D1 (en) Ankheit
ATE511030T1 (de) Mehrteiliger axialkäfig für ein grosswälzlager
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
WO2009114756A3 (en) Biomarkers for inflammatory bowel disease and irritable bowel syndrome
WO2008106648A3 (en) Immunoassays exhibiting a reduction in prozone phenomena
PT2129391E (pt) Método de diagnóstico
WO2010075360A3 (en) Methods for detection of sepsis
MX336280B (es) Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal.
WO2011143574A3 (en) Plasma biomarkers for diagnosis of alzheimer's disease
DE112005001558A5 (de) Verfahren für den Nachweis der Herkunft von Banknoten
BRPI0615415A2 (pt) método para melhorar a capacidade de remoção de água de lodo
MX2012003168A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal.
BRPI0606685A2 (pt) anticorpos gitr para o diagnóstico de nsclc
AU2010209763A8 (en) Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof
WO2008149364A3 (en) Methods for diagnosing hypersensitivity reactions
DE602007011542D1 (de) Schätzsystem für einen Indikator für Körperzusammensetzungen
WO2006091861A8 (en) Compositions and methods relating to cns lymphoma
WO2009098451A3 (en) Biomarkers of aminopeptidase inhibition
ATE440937T1 (de) Flüssiges reinigungsmittel für feste oberflächen
DE602006005182D1 (de) Wälzlager für Hilfsaggregate von Kraftfahrzeugen mit der Fähigkeit Abblättern durch Verspröden zu verhindern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties